PCVs have important indirect effects on reducing vaccine-type carriage and invasive pneumococcal disease. A 2+1 dosing schedule of PCVs provides both direct and indirect protection across populations by inducing sustained functional antibody responses after boosting. More evidence comparing the direct and indirect protective effects of 3+0 and 2+1 PCV schedules is forthcoming.